Difference between revisions of "Team:XJTU-China/Model"

(lab renew)
(lab renew2)
Line 1: Line 1:
<!-->{{XJTU-China}}
 
{{XJTU-China/Header}}
 
<html>
 
<head>
 
    <style type="text/css">
 
        #container {
 
  width: 100%;
 
  height: 100vh;
 
  position: relative;
 
  overflow: hidden;
 
}   
 
#nav {
 
line-height:30px;
 
height:300px;
 
width:300px;
 
float:right;
 
padding:5px;
 
position: fixed;
 
}
 
#section {
 
/*width:350px;*/
 
float:left;
 
padding:10px;
 
 
}
 
    </style>
 
</head>
 
<script type="text/x-mathjax-config">
 
MathJax.Hub.Config({  tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]}});
 
</script>
 
<script src="https://2018.igem.org/common/MathJax-2.5-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
 
</script>
 
 
  <body>
 
  <div id="nav">
 
<li><a href="#Model-A">Model A</a></li>
 
<li><a href="#Model-B">Model B</a></li>
 
<li><a href="#Model-C">Model C</a></li>
 
<li><a href="#Model-D">Model D</a></li>
 
</div>
 
  <div id="universal-wrapper">
 
 
    <div class="container">
 
      <h1 class="font-weight-bold text-center">Models</h1>
 
<div id= "section">
 
      <p align="center"><img src="https://static.igem.org/mediawiki/2018/8/87/T--XJTU-China--LYBMHJP_20180930.png"width="160"/></p>
 
      <br><br>
 
      <div align="center"><img src="https://static.igem.org/mediawiki/2018/8/86/T--XJTU-China--181015XJTU_model_test02.gif"width="400"/></div>
 
 
<a name="Model-A"></a><!--设置锚点方法1-->
 
<h2>Model A</h2>
 
      <h3>Overview</h3>
 
 
      <p>
 
        In our design, we aim to manufacture psicose, which has a lot of advantages over other sugar or sweetener as is mentioned in the research of the psicose. The advantages of psicose include low energy, benefit to diabetes and hyperlipidemia, making psicose become more and more popular in people. People can get a psicose sweetener or food rich in psicose, in which psicose is synthesized by biological ways, because using chemical ways is not a good choice to synthesize clear and edible psicose in a food grade for the containing of unhealthy and poisonous by-product in chemical synthesis methods.
 
<br><br>
 
<br>Latex demo:
 
$$|x_1-x_2|=\sqrt{x_1^2+x_2^2-2|x_1||x_2|\cos(x_1,x_2)}\,,\,\,x_1,x_2\in R^n$$
 
$$|x_1-x_2| = \sqrt{1+1-2\cos(x_1,x_2)}\,,\,\,x_1,x_2\in R^n, |x_1|=|x_2|=1$$
 
 
      </p>
 
      <p>
 
        Nevertheless, biological methods in producing psicose are inefficient due to the low enzyme efficiency of D-psicose 3-epimerase. The efficiency of D-psicose 3-epimerase is different due to the various environment system and the different concentration of substrate( sounds amazing due to the efficiency of enzyme irrelevant in most occasions). As a result, the temperature, PH value and the concentration are considered in our model to describe the efficiency of D-pisocose 3-epimerase, which is significant in our manufacture.
 
      </p>
 
      <p>
 
        Although the market size is estimated large enough from the market research we have made, modeling is needed to describe exactly how much is the efficiency of D-psicose 3-epimerase. we analysis the efficiency of D-psicose 3-epimerase is affected by the temperature, PH value and the concentration of substrate. In this way, we can predict the catalytic efficiency of D-psicose 3-epimerase by simulating the catalytic process.
 
      </p>
 
      <p>
 
        The third model we would like to model is the market model for the application of psicose. From the research, the conclusion that the psicose is very much needed among public and patients is analyzed. By the statistics we get, the potential market and the value curve of psicose appear from our mind by running the market model.
 
      </p>
 
      <ul>
 
        <li>
 
          Psicose Synthesis Kinetic Model
 
        </li>
 
        <li>
 
          Production Simulink Model
 
        </li>
 
        <li>
 
          Market and Price Model
 
        </li>
 
        <li>
 
          Microfluidics Model
 
        </li>
 
      </ul>
 
      <h3>Psicose synthesis kinetic model</h3>
 
      <p>
 
        In our design, the DTE process is one of the most significant part in manufacturing psicose. The main process of psicose manufacture is catalyzed by D-psicose 3-epimerase. The models of device A, B, C and D are as follows.
 
      </p>
 
      <img src="https://static.igem.org/mediawiki/2018/8/87/T--XJTU-China--LYBMHJP_20180930.png" alt="DeviceA" />
 
      <p>
 
        In device A, extracellular concentration of <i>psicose</i> is higher than which is intracellular, so it can enter the cells by diffusion. As a small molecular, the <i>psicose</i> inside the cell can be combined with <i>pPsiR</i> to generate cci. <i>pPsiR</i> is a repressor, which can bind to promoters on DNA and block gene expression. After binding with <i>psicose</i>, <i>pPsiR</i> falls off from the promoter and the gene starts expressing, And eventually produce the produce <i>EGFP</i>.
 
      </p>
 
      <p>
 
        For device A, the dynamic equation can be listed as follows:
 
      </p>
 
      <p>
 
        Concentrations of A and B are different inside and outside the cell, so the diffusion rate of  is proportional to the concentration difference between inside and outside of the cells. The $$psicose$$ is the concentration of psicose.The $psicose$ is the concentration of psicose.
 
      </p>
 
      $$$$
 
      <p>Where  is the diffusion coefficient.</p>
 
      <br />
 
      <br />
 
      <br />
 
      <br />
 
      <br />
 
      Finally, based on the probability distribution function, the variation of production is defined and we can compare the psicose production in natural system and directed evolution system.
 
      <h3>Results and Discussion</h3>
 
      <h3>Strengths and Prospect</h3>
 
      <p></p>
 
      <h3>Reference</h3>
 
      <span class="reference-text">
 
        Schmidt F R. Optimization and scale up of industrial fermentation processes.[J]. Appl Microbiol Biotechnol, 2005, 68(4):425-435.<br>
 
        Lin P Y, Whang L M, Wu Y R, et al. Biological hydrogen production of the genus Clostridium: Metabolic study and mathematical model simulation[J]. International Journal of Hydrogen Energy, 2007, 32(12):1728-1735.<br>
 
        Whang L M, Hsiao C J, Cheng S S. A dual-substrate steady-state model for biological hydrogen production in an anaerobic hydrogen fermentation process[J]. Biotechnology & Bioengineering, 2010, 95(3):492-500.<br>
 
        Rousu J, Elomaa T, Aarts R. Predicting the speed of beer fermentation in laboratory and industrial scale[J]. 1999, 1607.
 
      </span>
 
  <a name="Model-B"></a><!--设置锚点方法1-->
 
<h2>Model B</h2>
 
 
 
<a name="Model-C"></a><!--设置锚点方法1-->
 
<h2>Model C</h2>
 
 
 
<a name="Model-D"></a><!--设置锚点方法1-->
 
<h2>Model D</h2>
 
      <br>
 
</div>
 
      </div>
 
    </div>
 
  </body>
 
</html>
 
{{XJTU-China/Footer}}<-->
 
 
{{XJTU-China}}
 
{{XJTU-China}}
 
{{XJTU-China/Header}}
 
{{XJTU-China/Header}}

Revision as of 23:52, 15 October 2018

Modelling

       

In order to predict the concentration of different substance in E.coli, we set the kinetic model according to the reaction rate theory and enzymatic reaction kinetics as our first model in our project. And the production and conversion rate model is included to simulate the directed evolution model and the natural evolution model, and then we can get the time we need in our directed evolution method of DTE. The third model we set up is the microfluidics model to predict and simulate the situation in the microfluidics chip, which is our hardware for the gradient concentration of the psicose and antibiotic to let us have a high throughput experiment. The fourth model we set is the market model to predict the future market and the coefficient between different age groups and the tendency to adopt psicose.

      
  1. Psicose Synthesis Kinetic Model
  2.   
  3. Production Simulink Model
  4.   
  5. Market Model
  6.   
  7. Microfluidics Model
   

In our design, the DTE process is one of the most significant part in manufacturing psicose. The main process of psicose manufacture is catalyzed by D-psicose 3-epimerase. The models of device A, B, C and D are as follows.

In device A, extracellular concentration of $psicose$ is higher than the intracellular concentration, so it can enter the cells by diffusion. As a small molecular, the $psicose$ inside the cell can be combined with $pPsiR$ to generate $CCI$. $pPsiR$ is a repressor, which can bind to promoters on DNA and block gene expression. After binding with $psicode$,$pPsiR$ falls off from the promoter and the gene starts expressing, And eventually produce the produce $EGFP$.


For device A, the dynamic equation can be listed as follows:

Concentrations of A and B are different inside and outside the cell, so the diffusion rate of $psicose$ is proportional to the concentration difference between inside and outside of the cells.

$$\frac{\text{d}[PsiO]}{ \text{d}t}V_{outside}=-\gamma_F([PsiO]-[PsiI])$$

Where $\gamma_F$ is the diffusion coefficient.

Consider the external solution as an infinitely solution, which means $V_{outside}\rightarrow\infty$ , so

$$\frac{\text{d}[PsiO]}{ \text{d}t}=0$$

When reducer psicose combines with repressor, the process is

$$PsiI+pPsiR\rightarrow CCI$$

Where $PsiI$ is the intracellular $psicose$, $pPsiR$ is $psicose$ dependent repressor and $CCI$ is $psicose$-repressor complex. The change in concentration of $PsiI$,$pPsiR$ and $CCI$ contains three influencing factors: the binding reaction of $pPsiR$ and $psicose$, and the degradation reaction of themselves and the reverse reaction. Here we consider the binding reaction as a second order reaction and the degradation reaction and reverse reaction as first order reactions. According to law of mass action, reaction rate is proportional to the product of the reactant concentration, so we have

$$\frac{\text{d}[PsiI]}{\text{d}t}=\frac{-\gamma_F([PsiI]-[PsiO])}{V_{cell}}-m_{pPsiR,Psi}[PsiI][pPsiR]+m_{CCI}[CCI]-\delta_{PsiI}[PsiI]$$

And considering $pPsiR$ is constantly expressing, we can get

$$\frac{\text{d}[pPsiR]}{\text{d}t}=\alpha_{pPsiR}-m_{pPsiR,Psi}[PsiI][pPsiR]+m_{CCI}[CCI]-\delta_{pPsiR}[pPsiR]$$

Where $m_{pPsiR,Psi}$ is the coefficient of reaction rate of the binding reaction, $\alpha_{pPsiR}$ is the rate of constant expression of $pPsiR$, $\delta_{pPsiR}$ and $\delta_{PsiI}$ are coefficients of reaction rate of the degradation reaction of $pPsiR$ and $PsicoseI$ respectively.


The concentration of inactivated repressor is

$$\frac{\text{d}[CCI]}{\text{d}t}=m_{pPsiR,Psi}[PsiI][pPsiR]+m_{CCI}[CCI]-\delta_{CCI}[CCI]$$

The change in $EGFP$ concentration depends on the concentration of its repressor, $pPsiR$ which can be described by Hill-equation. Considering $EGFP$ is also degrading, the equation is

$$\frac{\text{d}[EGFP]}{\text{d}t}=H\frac{\beta_{EGFP}K^n}{K^n+[pPsiR]^n} -\delta_{EGFP}[EGFP]$$

Where $n$ is hill coefficient, $K$ is the ligand concentration producing half occupation, $\beta_{EGFP}$ is maximal transcription rate of gene $EGFP$, and $H$ is a constant used to indicate the deviation between the theoretical and actual values.

In device B, extracellular concentration of $IPTG$ is higher than which is intracellular, so it can enter the cells by diffusion. As a small molecular, the $IPTG$ inside the cell can be combined with $pLacR$ to generate $CC$. $pLacR$ is a repressor, which can bind to promoters on DNA and block gene expression. After binding with $IPTG$, $pLacR$ falls off from the promoter and the gene starts expressing, And eventually produce the produce $EGFP$. Since the gene of $ABR$ and the gene of $EGFP$ are connected in series, they are expressed together.

Similarly, we can get the function of device B by using the reaction rate equation and the diffusion function. First,

$$\frac{\text{d}[IPTGO]}{\text{d}t}=0$$

According to the reaction between $IPTGI$ and $pLacR$ and the reaction rate equation, we can get

$$IPTGI+pLacR\rightarrow CC$$

This reaction is similar with the reaction in device A, so we have

$$\frac{\text{d}[IPTGI]}{\text{d}t}=\frac{-\gamma_{IPTG}([IPTGI]-[IPTGO])}{V_{cell}}-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{IPTG}[IPTGI]$$

Similarly, we can also get

$$\frac{\text{d}[pLacR]}{\text{d}t}=\alpha_{pLacR}-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{pLacR}[pLacR]$$

$$\frac{\text{d}[CC]}{\text{d}t}=-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{CC}[CC]$$

And $pLac$ is a transcription activator of gene $EGFP$, according to hill equation, the concentration of $EGFP$ is

$$\frac{\text{d}[EGFP]}{\text{d}t}=H\frac{\beta_{EGFP}K^n}{K^n+[pLacR]^n} -\delta_{EGFP} [EGFP] $$

The concentration of $EGFP$ is the same as the concentration of antibiotics resistance due to the transcription and translation of antibiotic resistance gene combined with the gene of $EGFP$.

$$\frac{\text{d}[EGFP]}{\text{d}t}=\frac{\text{d}[ABR]}{\text{d}t}$$

Where $[EGFP]$ is the concentration of $EGFP$ and $[ABR]$ is the concentration of antibiotic resistance protein expression.

Device C is the same with device B. The only difference is the hairpin between gene of $EGFP$ and gene of $RFP$. Similarly, we can get the function of hairpin and its coefficient.

The first few equations are the same as in device B:

$$\frac{\text{d}[IPTGO]}{\text{d}t}=0$$

$$\frac{\text{d}[IPTGI]}{\text{d}t}=\frac{-\gamma_{IPTG}([IPTGI]-[IPTGO])}{V_{cell}}-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{IPTG}[IPTGI]$$

$$\frac{\text{d}[pLacR]}{\text{d}t}=\alpha_{pLacR}-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{pLacR}[pLacR]$$

$$\frac{\text{d}[CC]}{\text{d}t}=m_{IPTG,pLacR}[IPTGI][pLacR]-m_{CC}[CC]-\delta_{CC}[CC]$$


$$\frac{\text{d}[EGFP]}{\text{d}t}=H\frac{\beta_{EGFP}K^n}{K^n+[pLacR]^n} -\delta_{EGFP} [EGFP]$$

The presence of the hairpin leads to a decrease in $RFP$ expression efficiency, so we have

$$\frac{\text{d}[EGFP]}{\text{d}t}=k\frac{\text{d}[RFP]}{\text{d}t}$$

Where $[RFP]$ is the concentration of red fluorescence protein, $k$ is the coefficient of hairpin.

In device D, $IPTG$ gets in cells and bind with $pLacR$, which is a repressor for gene $DTE$. After $IPTG$ binding with $pLacR$, $DTE$ starts to express, and as an enzyme, to catalysis $fructose$ to turn into $psicose$. As more and more $psicose$ are produced, more and more the repressor of gene $EGFP$, $pLacR$ are inactivated, so expression of $EGPF$ increase. At the same time, expression of $ABR$ also increase since the gene of $ABR$ and the gene of $EGFP$ are connected in series by a hairpin.

For device D, $psicose$ and $fuctose$ get in cells by diffusion:

$$\frac{\text{d}[PsiO]}{\text{d}t}=\frac{-\gamma_{F}([PsiO]-[PsiI])}{V_{outside}}=0 $$

$$\frac{\text{d}[FO]}{\text{d}t}=\frac{-\gamma_{F}([FO]-[FI])}{V_{outside}}=0$$

$$\frac{\text{d}[IPTGO]}{\text{d}t}=\frac{-\gamma_{F}([IPTGO]-[IPTGI])}{V_{outside}}=0$$

And device D consists of device A and device C connected by an extra step:

$$FI\underrightarrow{DTE}PsiI$$

This reaction is an enzyme catalyzed reaction, which can be described by Michaelis equation, so we can get the following equations:


$$\frac{\text{d}[FI]}{\text{d}t}=\frac{-\gamma_{F}([FI]-[FO])}{V_{cell}}-\frac{k_2[DTE][FI]}{K_M+[FI]}-\delta_{FI}[FI]$$

$$\frac{\text{d}[PsiI]}{\text{d}t}=\frac{-\gamma_{F}([PsiI]-[PsiO])}{V_{cell}}+\frac{k_2[DTE][FI]}{K_M+[FI]}-\delta_{PsiI}[PsiI]$$

$$\frac{\text{d}[IPTGI]}{\text{d}t}=\frac{-\gamma_{IPTG}([IPTGI]-[IPTGO])}{V_{cell}}+m_{IPTG,pLacR}[IPTGI][pLacR]-\delta_{IPTG}[IPTGI]$$


Where $k_2$ is reaction rate coefficient of transition state product’s decomposition reaction, $K_M$ is the Michaelis contant.


The rest of the equations are the same with which in device A and device C:

$$\frac{\text{d}[pLacR]}{\text{d}t}=\alpha_{pLacR}-m_{IPTG,pLacR}[IPTGI][pLacR]+m_{CC}[CC]-\delta_{pLacR}[pLacR]$$

$$\frac{\text{d}[pPsiR]}{\text{d}t}=\alpha_{pPsiR}-m_{pPsiR,PsiI}[pPsiR][PsiI]+m_{CCI}[CCI]-\delta_{pLacR}[pLacR]$$

$$\frac{\text{d}[pPsiR]}{\text{d}t}=\alpha_{pPsiR}-m_{pPsiR,Psi}[PsiI][pPsiR]+m_{CCI}[CCI]-\delta_{pPsiR}[pPsiR]$$

$$\frac{\text{d}[CC]}{\text{d} t}=m_{IPTG,pLacR}[PsiI][pPsiR]-m_{CC}[CC]-\delta_{CC}[CC]$$

$$\frac{\text{d}[CCI]}{\text{d} t}=m_{pSiR}[PsiI][pPsiR]-m_{CCI}[CCI]-\delta_{CCI}[CCI]$$

$$\frac{\text{d}[DTE]}{\text{d}t}=H\frac{\beta_{EGFP}K^n}{K^n+[pLacR]^n}-\delta_{DTE}[DTE]$$

$$\frac{\text{d}[EGFP]}{\text{d}t}=H\frac{\beta_{EGFP}K^n}{K^n+[pPsiR]^n}-\delta_{EGFP}[EGFP]$$

$$\frac{\text{d}[ABR]}{\text{d}t}=k\frac{\text{d}[EGFP]}{\text{d}t}$$

Basing our model, we can calculate and simulate our system as follows:

From the picture below, it is evident that with time going by, the concentration of IPTG outside the cell will decrease due to the diffusion process, while the RFP expression level is increasing stably.

If we do more experiments shown below, we can find that the expression level of RFP is increasing with the increase of the concentration of IPTG, which proves that we can get a linear range of IPTG to get the RFP expression level. According to device A, B, C, D, this conclusion can also be made, which proves the validation of our kinetic model

Reference

Schmidt F R. Optimization and scale up of industrial fermentation processes.[J]. Appl Microbiol Biotechnol, 2005, 68(4):425-435.
Lin P Y, Whang L M, Wu Y R, et al. Biological hydrogen production of the genus Clostridium: Metabolic study and mathematical model simulation[J]. International Journal of Hydrogen Energy, 2007, 32(12):1728-1735.
Whang L M, Hsiao C J, Cheng S S. A dual-substrate steady-state model for biological hydrogen production in an anaerobic hydrogen fermentation process[J]. Biotechnology & Bioengineering, 2010, 95(3):492-500.
Rousu J, Elomaa T, Aarts R. Predicting the speed of beer fermentation in laboratory and industrial scale[J]. 1999, 1607.